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Abstract. Cytoskeletal rearrangement occurs in a variety
of cellular processes and involves a wide spectrum of
proteins. Among these, the gelsolin superfamily proteins
control actin organization by severing filaments, capping
filament ends and nucleating actin assembly [1]. Gelsolin
is the founding member of this family, which now con-
tains at least another six members: villin, adseverin,
capG, advillin, supervillin and flightless I. In addition to
their respective role in actin filament remodeling, these
proteins have some specific and apparently non-overlap-
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ping particular roles in several cellular processes, includ-
ing cell motility, control of apoptosis and regulation of
phagocytosis (summarized in table 1). Evidence suggests
that proteins belonging to the gelsolin superfamily may
be involved in other processes, including gene expression
regulation. This review will focus on some of the known
functions of the gelsolin superfamily proteins, thus pro-
viding a basis for reflection on other possible and as yet
incompletely understood roles for these proteins.
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Introduction
The gelsolin protein superfamily is a conserved family of
proteins present in mammalian as well as in non-mam-
malian organisms. This  review will focus on the role of
gelsolin and gelsolin-related proteins in mammals. Gel-
solin superfamily consists of seven different proteins:
gelsolin, adseverin, villin, capG, advillin, supervillin and
flightless I. All contain three or six homologous repeats
of a domain named gelsolin-like (G) domain (fig. 1A).
Gelsolin, a protein of 82–84 kDa, is the founding mem-
ber of this family, exists as a cytoplasmic as well as a
plasma isoform, and can bind, sever and cap actin fila-
ments (reviewed in [2]). These isoforms are encoded by a
single gene on chromosome 9 [3, 4]. The two messenger
* Corresponding author.
RNAs (mRNAs) encoding cytoplasmic and plasma iso-
forms result from alternative splicing and use alternative
transcriptional initiation sites. Gelsolin is expressed in a
wide variety of cell types. Its secreted form differs from
the intracellular one by a 25-amino acid signaling peptide
and the presence of a disulfide bond between cysteine
residues at positions 188 and 201 [3, 5]. Recent studies
show that the plasma gelsolin level decreases dramati-
cally as a result of major trauma, and that reinfusion of
gelsolin can protect against lung damage associated with
major burn injury and other types of insults [6–8].
Recently, a third isoform (gelsolin-3) has been described
[9]. Gelsolin-3 is cytoplasmic and is characterized by 11
additional residues at the N-terminus. Gelsolin-3 is ex-
pressed in oligodendrocytes and mainly in the brain,
lungs and testis [9], but its specific function is still un-
known.
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Table 1. Summary of  the main proven cellular functions for gelsolin superfamily proteins.
Number of Cellular functions
gelsolin-
like domains Regulation of Exocytosis Cell motility Phagocytosis Apoptosis Platelet for-
actin dyna- mation and
mics activation




Adseverin 6 + + ? + +
(complement-me-
diated phagocytosis)







Absence of an indication means absence of studies addressing the specific role of a protein in the cellular process concerned. 
Figure 1. Schematic representation of gelsolin structure (A). Residues are numbered as in human plasma gelsolin. Gelsolin can bind, sever
and cap actin filaments (B). Actin molecules within a filament are shown as red circles. (+) and (–) indicate barbed and minus ends of actin
filament, respectively. After binding to actin filament, and in response to an increase in intracellular Ca2+ concentration, gelsolin undergoes
a change in conformation that allows the severing process to proceed. After severing, gelsolin remains attached to the barbed end of actin
filament as a cap.
Gelsolin contains six gelsolin-like (G) domains and was
first described as a protein able to bind and sever actin fil-
aments, and to control polymerization of barbed ends.
Furthermore, this protein also initiates formation of actin
filaments by binding two monomeric actin molecules.
Gelsolin activity is regulated by Ca2+, intracellular pH,
phosphoinositides and tyrosine phosphorylation. Crystal-
lographic studies of gelsolin complexed with its substrate
have been recently performed [10–14]. Results have
been reviewed in [15] and will not be discussed here. 
The other gelsolin superfamily members; villin, advillin,
supervillin and flightless, have additional domains be-
yond the sixfold repeat. Villin has been demonstrated to
participate in cytoskeleton remodeling in response to var-
ious stimuli in the intestine [16]. Flightless is the only
member of gelsolin superfamily that has been shown to
be essential for mouse development [17]. Among all of
the proteins forming the gelsolin superfamily, adseverin
(also named scinderin) is the one that shares the highest
degree of homology with gelsolin. Indeed, adseverin
shares 60% amino acid homology with gelsolin [18], and
displays Ca2+-regulated actin filament severing activity.
As compared to gelsolin, adseverin has a more restricted
expression. Adseverin was first discovered in platelets,
megakaryocytes and chromaffin cells [19]. This protein is
present in all secretory cells and is involved in actin cy-
toskeleton remodeling occurring during exocytosis
[19–22]. With flightless [23] and supervillin [24, 25],
capG (also named gCap39, Mbh1 or macrophage capping
protein) is the only other protein of gelsolin family shar-
ing a nuclear localization [26, 27]. CapG only contains
three  G domains and can bind and cap actin filaments but
cannot sever them [28]. CapG has been demonstrated to
play an important role as a mediator of endothelial cell re-
sponse to mechanical forces [29].
Actin filament remodeling
In the absence of Ca2+, gelsolin exists in a globular con-
formation. Crystal structure analysis has revealed the ex-
istence of a C-terminal tail (‘latch helix’) which is in
close contact with the actin binding region of G2 domain.
The importance of this latch helix in Ca2+ regulation of
gelsolin-actin interactions was first revealed by the
demonstration that a lack of 20 residues in the C-termi-
nus tail abrogates the Ca2+ regulation of actin binding [30,
31]. The latch hypothesis suggests that Ca2+ binding to G6
domain induces a first conformational change in the gel-
solin structure, releasing tail latch inhibition of G2 bind-
ing to actin. G2 binding to actin directs the G1 domain to
its actin binding site. In the absence of Ca2+, G4 and G6
domains are close together. Ca2+ opens this structure, and
the G6 domain forms new contacts with the G5 domain,
releasing the G4 domain, which now can form a Ca2+
binding domain coordinated by actin and G4 itself. The
actin binding sites at the N- and C-terminal parts bind to
two adjacent actin filaments. Slowly, gelsolin severs the
two actin filaments, remaining bound to the newly
formed actin + end (barbed end) of one of the two shorter
filaments (fig. 1B). Further uncapping of actin filaments
requires binding of gelsolin to phosphatidylinositol
lipids. This process exposes the barbed end for polymer-
ization [32, 33]. Until recently, phosphatidylinositol 3,4
or 4,5-bisphosphate (PIP2) isomers were the only known
intracellular agents inhibiting gelsolin severing and in-
ducing dissociation of gelsolin from actin. More recently,
another protein of bacterial origin was shown to inhibit
gelsolin severing activity. Indeed, some bacteria have the
possibility to infiltrate cells delivering effector proteins
that trigger a cytoskeleton rearrangement and membrane
ruffling (reviewed in [34, 35]). Salmonella invasion pro-
tein a (SipA) is one of these proteins. SipA promotes
actin polymerization, inducing an arrest of actin turnover.
This arrest is partly exerted through inhibition of severing
activity of gelsolin [36]. 
Additional evidence exists proving that tyrosine phos-
phorylation can also induce conformational change in
villin and gelsolin proteins, promoting their severing ac-
tivities at submicromolar concentrations of Ca2+ [37]. An
additional factor that has been shown to regulate actin
network reorganization via gelsolin is intracellular pH. It
has been demonstrated that the Ca2+ requirement for both
severing and nucleating activities decreases with lowered
pH. Half-maximal activities require 10 mM Ca2+ at a pH
of 7.4 and decrease to 3 mM at pH 6.5. At low pH direct
activation of gelsolin severing activity can also be ob-
served in complete absence of Ca2+. This feature is not
general to other gelsolin superfamily members and may
be due to a conformational change of gelsolin occurring
at low pH [38], resulting in increased association of gel-
solin with actin. This increase is similar to that observed
at pH 7.0 in the presence of Ca2+. Finally, low pH-acti-
vated gelsolin can still be inhibited by PIP2.
Cell motility
Properties of the cytoskeleton depend on different para-
meters, such as filament length, flexibility, concentration
and presence of cross-links. Proteins with the capacity to
alter such properties are potentially important for regu-
lating cellular morphology and function, as is the case for
cell shape and regulation of cell motility. A first clue to
evidence of the link between the expression of gelsolin or
gelsolin-related proteins and cell motility was provided
by transfection experiments of cultured fibroblasts [39].
Overexpression of gelsolin in these cells resulted in in-
creased motility and concomitant inhibition of phospho-
lipase C (PLC) -b and -g [40, 41]. Surprisingly, despite
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the lack of severing activity, capG  overexpression also
increased fibroblast motility [42].
Gelsolin has also been shown to regulate hematopoietic
stem cell motility. Lin–Sca+Kit+ and Lin–Sca+Kit–, are two
hematopoietic stem cell populations which show different
basal and induced motility capacity. Indeed, they exhibit
differential cell motility in response to stromal derived fac-
tor 1 (SDF-1), a chemokine influencing cell motility
through phosphatidylinositol signaling. Lin–Sca+Kit+ cells,
which are more primitive than Lin–Sca+Kit– cells, exhibit a
lower response in terms of cell motility, although the acti-
vation of the phosphatidylinositol pathway was activated at
the same level in the two populations. Proteomics analysis
documented a lower expression of gelsolin and adseverin
in Lin–Sca+Kit+ than in Lin–Sca+Kit–, providing an expla-
nation for this differential response to SDF-1 [43].
CapG, which lacks severing activity, has also been shown
to be involved in regulation of cellular motility in fibrob-
lastic cells [42]. More recently, we were able to demon-
strate that capG is also an important regulator of motility
function in endothelial cells [29]. Endothelial cells are
able to discriminate between different combinations of
mechanical forces. In vivo, this capability results in a fo-
calization of vascular areas subjected to atherosclerotic
plaque development [44–46]. Indeed, plaques develop at
bifurcations and curvatures which are exposed to a par-
ticular pattern of blood flow, with a low mean shear stress
value and cyclic reversal of flow direction, which is in
contrast with the unidirectional pattern of flow character-
izing vascular areas protected against plaque develop-
ment. In response to a plaque-free hemodynamic envi-
ronment, capG expression and consequently endothelial
motility are increased [29], resulting in a faster wound
healing process [47], as compared to endothelial cells ex-
posed to plaque-prone conditions. 
In vivo evidence for gelsolin involvement in cell motility
was provided by gelsolin null mice (Gsn–/–), in which
motility of osteoclasts was decreased [48]. In these mice,
osteoclasts were unable to form cell adhesion structures
(podosomes), and therefore their basal as well as their os-
teopontin-induced motility was affected. Analysis of
these mice identified an additional role of gelsolin in the
regulation of neuronal growth, cone formation and re-
traction [49]. Neuronal growth cones are highly motile
structures from which lamellipodia and filopodia form
and retract. Formation of these structures is a Ca2+-con-
trolled process dependent on actin cytoskeleton remodel-
ing. In Gsn–/– mice, only retraction processes appeared
to be delayed, as compared to wild-type mice, suggesting
that retraction is solely dependent on the presence of gel-
solin, whereas formation of filopodia is mainly depen-
dent on adseverin activity (adseverin  is indeed expressed
in these cells) [49]. Finally, knockout mice revealed the
essential role of capG in macrophage ruffling [50]. In-
deed, macrophages rapidly change shape forming protru-
sions resulting from local actin filament assembly [51], a
process that is Ca2+ sensitive. In capG–/– mice, but not in
Gsn–/– mice, basal and macrophage colony stimulating
factor (MCSF)-induced ruffling activities were decreased
[50].
A further role in phagocytosis
Phagocytosis is a complex cellular process that necessi-
tates a continuous rearrangement of actin cytoskeleton. In
polymorphonuclear leukocytes three types of phagocyto-
sis can be distinguished: a complement-opsonized, im-
munoglobulin G (IgG)-opsonized, and integrin-mediated
phagocytosis. This latter is essential for remodeling of
connective tissue. The three types of phagocytosis are
mediated by three separate sets of cell surface receptors:
the complement receptors (CRs), the Fcg receptors and
integrin molecules [52–54]. Using Gsn–/– mice, it has
been possible to demonstrate that gelsolin plays a pri-
mordial role in Fc receptor- and integrin- but not in com-
plement-mediated phagocytosis [50, 54–56]. Other func-
tions associated with Fc receptor-mediated phagocytosis,
such as the activation of NADPH-oxidase, were not af-
fected in Gsn–/– mice [55]. An impairment of comple-
ment-opsonized phagocytosis was observed in capG/Gsn
double-null mice, providing evidence for distinctive and
non-overlapping functions of capG and gelsolin in
phagocytic processes [50]. Finally, binding and internal-
ization of collagen beads, a process dependent on a2b1
integrin [53], was also shown to be affected in Gsn–/– fi-
broblasts [56]. Despite the obvious need for actin cy-
toskeleton remodeling, allowing cells to undergo phago-
cytosis, details of the mechanisms relating gelsolin and
capG to this process are not yet clear. Work addressing
the mechanisms of regulation of actin dynamics in the
context of cell migration revealed a role of gelsolin as a
downstream effector of the GTP-binding protein Rac
[57–59]. Once activated, Rac promotes dissociation of
gelsolin and actin, allowing actin remodeling to proceed
[57].  Rac activation is also a key step in Fc receptor- and
integrin-mediated phagocytosis [56, 60–63], and was
shown to be affected in Gsn–/– fibroblasts, providing a
first possible step in the mechanisms controlling phago-
cytosis process. Indeed, in Gsn–/– fibroblasts, activation
of Rac after binding to collagen was impaired compared
to wild-type fibroblasts [56]. This activation could be re-
stored after transfection of Gsn–/– cells with gelsolin-ex-
pressing constructs and with calcium ionophores [56].
Based on these results, the authors proposed a mecha-
nism starting from a gelsolin-mediated remodeling of
actin cytoskeleton necessary for a subsequent calcium in-
flux and  Rac activation. This situation is probably more
complicated because of the need of Rac for gelsolin-actin
dissociation [57–59].
CMLS, Cell. Mol. Life Sci. Vol. 61, 2004 Review Article 2617
Gelsolin and apoptosis
The apoptotic process is activated through a cascade of as-
partate-specific cysteine protease family named caspases.
Fourteen members of this family are known in mammals
and are present in the cell as precursors (zymogens). They
can be divided into two main groups: the first group is ac-
tivated following apoptotic stimuli and their major role is
to activate downstream caspases. They are aggregated by
caspase adaptor molecules (FAS-associated proteins with
death domain, or Apaf-1), which promote autoactivation.
The second group of caspases, the executioners (caspases-
3, -6 and -7), are activated by apical caspases (reviewed in
[64, 65]). Once activated, executioner caspases will cleave
structural proteins and proteins involved in the repair
process. One of the targets of caspase-3 is gelsolin [66].
Indeed, this enzyme cleaves gelsolin protein at D352 of the
DQTD352G sequence, generating two fragments of 39 and
41 kDa. Cleaved gelsolin loses Ca2+ control of severing
activity and the capacity to bind monomeric actin. Mi-
croinjection of the N-terminal gelsolin fragment (1–352),
which contains the severing activity, but not of the COOH-
terminal fragment (353–731), triggered rapid depolymer-
ization of the actin cytoskeleton [66]. Moreover, HeLa
cells that normally do not express gelsolin are rendered
more susceptible to apoptosis by overexpressing gelsolin
[66]. Caspases other than caspase-3 have been suggested
to be capable of cleaving gelsolin. In MCF-7 breast carci-
noma cells lacking caspase-3 activity, gelsolin was still
cleaved during an apoptotic process triggered by Fas anti-
body or tumor necrosis factor (TNF) [67]. Nevertheless,
in more recent work, a possible cleavage of gelsolin by
one of the two other executioner caspases (-6 and -7) was
excluded using a cell-free system depleted of each of these
caspases. Only in the absence of caspase-3 was gelsolin
not cleaved [68]. 
Gelsolin behaves not only as a regulator but also as an in-
hibitor of the apoptotic process. Initial evidences of such
a dual effect of gelsolin was provided by the observation
that a point mutation in mouse gelsolin confers on this
protein tumor-suppressor activity against H-ras oncogene-
transformed NIH 3t3 cells [69, 70]. Moreover, transfec-
tion of the gelsolin gene in a human bladder cancer cell
line strongly reduced colony-forming ability and tumori-
genicity in vivo [71]. More direct evidence of the in-
hibitory role of gelsolin was provided by Ohtsu et al., who
generated Jurkat transfectants expressing up to threefold
more gelsolin than wild-type cells. These transfectants ex-
hibited a phenotype more resistant to apoptosis induced
by several stimuli [72]. Different mechanisms have been
proposed to explain such an inhibitory capacity. First,
overexpression of gelsolin was demonstrated to prevent
caspase-3 activation [72]. Second, using a cell-free system
to study the apoptotic process, Azuma et al. were able to
show that gelsolin can form a complex with PIP2 and cas-
pase-3 to inhibit caspase-3 activity [73]. In the same work,
the authors were able to demonstrate that gelsolin-PIP2
complex forms in vivo and that the formation of this com-
plex correlates with a delay in the apoptotic process. An-
other hypothesis, explaining the inhibitory action of gel-
solin overexpression in the apoptotic process, involves its
possible action at the level of mitochondrial membrane
potential. Indeed, one of the first stages of apoptosis is an
increase in permeability of the mitochondrial membrane.
Loss of cytochrome c has been linked to this loss of mem-
brane potential [74, 75]. When cytochrome c associates to
the caspase-9/Apaf 1 complex, it triggers activation of an
effector caspase [65]. Overexpression of gelsolin pre-
vented this loss in mitochondrial membrane potential
[76]. Gelsolin has been proposed to participate in regula-
tion of apoptosis by binding to voltage-dependent anion
channel (VDAC), the putative permeability transition pore
[77]. Gelsolin-mediated protection against apoptosis is in-
hibited by phosphoinositides known to bind with high
affinity to gelsolin,  suggesting that the effect of gelsolin
is due to its conformation or to its ability to bind actin
[78–80]. The observation that in gelsolin-null mice neu-
rons exhibit enhanced apoptosis due to hypoxia after a
stroke further supports the hypothetic inhibitory action of
gelsolin on apoptosis. In this work a protective role of gel-
solin on neuronal cells in such conditions has been sug-
gested [81].
Despite all these data, the inhibitory action of gelsolin on
apoptosis remains controversial. Indeed, Posey et al. re-
cently failed to observe a delay in Fas-induced apoptotic
processes following different stimuli in T lymphocytes
overexpressing gelsolin [82]. This discrepancy could
eventually be explained by different pathways leading to
apoptosis. Indeed, Fas-ligand can induce apoptosis via
two mechanisms, one of which involves caspase-8 activa-
tion, and that is independent of changes in mitochondrial
membrane potential [82]. Alternatively, differences on
basal and transfected gelsolin expression in the cell pop-
ulations used could explain this lack of effect.
Role of the gelsolin superfamily during development
Despite the variety of processes in which gelsolin and
other related proteins have been involved, Gsn–/–,
capG–/– and Gsn/capG double null mice do not exhibit
developmental disorders. This is probably due to the re-
dundancy in the functions of these proteins. Mice lacking
the gelsolin gene reproduce and develop normally, but
adult mice exhibit some alteration in cellular processes
involving cell motility. In these mice, bleeding time is in-
creased, suggesting an alteration in platelet function, and
the inflammatory process is affected because of a de-
creased migratory capacity of neutrophils and decreased
motility of fibroblasts, resulting in slower wound healing
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[83]. Interestingly, Gsn –/– also showed some develop-
mental alterations, such as delay in postnatal mammary
gland development [84]. Ductal outgrowth was delayed
until week 9, and the mammary epithelium was unre-
sponsive to hormone stimulation. Osteoclasts were de-
void of podosomes, a cell-adhesion structure. Despite the
observation that gelsolin null mice do not display any
neuronal defects, alterations were observed in formation
of the growth cone of neurites [49]. 
Analysis of gelsolin, adseverin and capG proteins during
mouse development has revealed complementary expres-
sion patterns for these proteins. Gelsolin mRNA is pre-
sent in multiple tissues, with the highest levels in cardiac
ventricle, diaphragm and other muscles. Adseverin ex-
pression is limited to endochondral bone primordial, re-
nal tubules and intestinal microvilli during embryogene-
sis. CapG is expressed in squamous epithelia, as well as
specific regions of the kidney, adrenal gland and spleen
and in the developing brain cortex [85]. In adult mice, ad-
severin expression is mainly observable in the kidney and
in the intestine, and capG expression is strongly ex-
pressed in the heart, in uterus, lung, kidney and at a lower
level in other tissues. Gelsolin is strongly expressed in the
heart and lung, and at a lower level in skeletal muscle,
kidney and testis [85].
In zebrafish, gelsolin has been shown to be specialized
for high corneal expression [86], and to be required for
proper dorsalization during embryogenesis [87].
Finally, fliih, the mouse homologue of Drosophila
melanogaster flightless I, is the only protein belonging
gelsolin superfamily family essential for normal mouse
development [17]. Disruption of the fliih gene in mice re-
sults in a rapid degeneration of the embryo. Recently,
flightless I was shown to function as a nuclear coactivator
in response to estrogen stimulation in MCF-7 cells [23].
Platelet activation
Platelet formation and activation are processes that in-
volve reorganization of the actin cytoskeleton. Indeed,
platelets form from megakaryocytes after proliferation,
differentiation, nuclear polyploidization and apoptosis
[88, 89]. Mature megakaryocytes form long and thin cy-
toplasmic extensions, from which platelets are released.
This process is highly related to remodeling of the actin
cytoskeleton [90]. Megakaryoblastic cells express gel-
solin, but not adseverin and capG [91]. Forced expression
of adseverin induces megakaryoblastic cell maturation,
leading to platelet formation [91]. Interestingly, expres-
sion of adseverin also causes downregulation of gelsolin
expression, suggesting that adseverin may act as an apop-
tosis regulator in megakaryoblastic cells, while gelsolin
protects megakaryoblasts from apoptosis, inhibiting their
final differentiation process. These data strongly support
an important role of gelsolin and related proteins in the
regulation of platelet formation. Evidence exists that
these proteins also play a role also in platelet activation.
The first stage in this process is a change in cell shape
[92], which depends on actin filament remodeling. In
resting platelets actin filaments are stabilized by VASP, a
cytoskeleton focal adhesion protein which shows actin
binding properties. VASP protects actin filaments from
the severing effects of gelsolin but does not inhibit gel-
solin from binding to the filaments [93]. Moreover, rest-
ing platelets contain ~2 mM Cap Z, a calcium-insensitive
heterodimeric capping protein associated with the barbed
ends of actin filaments [94], thus protecting barbed ends
from polymerization. After stimulation, rapid severing
activity of existing actin filaments is triggered [95]. This
process allows amplification of barbed ends. Dissocia-
tion of gelsolin and CapZ from barbed ends, necessary
for actin filament polymerization, necessitates phospho-
inositide 3-kinase (PI3-kinase) activity [96]. Changes in
platelet cell shape are dependent on a rise in intracellular
Ca2+ and PI3-kinase activity [97, 98]. As a consequence
of this remodeling process cells lose their resting discoid
form in favor of an activated form with long thin filopods
containing bundles of F-actin.
Familial amyloidosis of the Finnish type
Although the role of plasma gelsolin is still not com-
pletely understood, it is now known that a mutation in cir-
culating gelsolin is the basis for a genetic disease. Indeed,
association of a mutation at position 187 of the gelsolin
gene with familial amyloidosis of the Finnish type (FAF)
has been described [99–103]. FAF is an autosomal, dom-
inant amyloid polyneuropathy, characterized by corneal
lattice dystrophy, progressive cranial and peripheral neu-
ropathy as well as skin changes. Mutation of Asn residue
a Tyr 187 results in destabilization of the G2 domain, pre-
dicting an unfolding that will predispose gelsolin to pro-
teolysis [104, 105]. This aberrant cleavage generates the
FAF amyloid precursor fragment of 68 kDa. Further
cleavage at position 244 is required for the generation of
FAF amyloid protein, which accumulates in patient tis-
sues [106–109]. Moreover, plasma gelsolin isolated from
homozygous FAF patients lacks both actin severing and
nucleating activities [104]. In contrast, cytoplasmic gel-
solin is not aberrantly cleaved in these patients [110], and
the normal actin modulating function of intracellular gel-
solin is not affected [111].
Concluding remarks
The major, intriguing observation concerning the gelsolin
superfamily proteins is that despite their key role in con-
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trolling cellular processes, involving cytoskeleton remod-
eling, deletion of their genes in many cases is not lethal
nor does it result in a clear phenotype. Processes involv-
ing cell shape changes and cell motility are slightly sup-
pressed, but not abrogated. This apparent paradox may be
explained by a compensatory mechanism by other pro-
teins belonging to this superfamily. This observation im-
plies that experiments affecting the expression of just one
of these proteins need to be carefully interpreted. The ex-
pression of the other gelsolin superfamily proteins has to
be assessed in the targeted cells and tissues. An absence
of effect does not necessarily means an absence of func-
tion in vivo. 
Several investigations still need to be performed in order
to completely understand the function of the protein
members of this family. Several aspects will need further
analysis, such as the increase in nuclear capG in endothe-
lial cells exposed to plaque-free flow [29]. In fact, the role
of nuclear capG is not yet clear. It has been demonstrated
that nuclear capG can interfere with nuclear PI3-kinase
[112]. This may eventually suggest that capG is involved
in phosphatidylinositol-driven chromatin remodeling
[113, 114] and therefore plays a role as a general regula-
tor of gene transcription. 
A better understanding of the function of gelsolin super-
family proteins will certainly help us in comprehending
cellular physiology.
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